HCM

和黄医药
NASDAQ

实时行情|Nasdaq Last Sale

17.93
+0.13
+0.73%
盘前: 17.17 -0.76 -4.24% 07:43 04/03 EDT
开盘
17.86
昨收
17.80
最高
18.01
最低
17.28
成交量
10.42万
成交额
--
52周最高
32.55
52周最低
14.74
市值
24.76亿
市盈率(TTM)
-224.9686
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测HCM价格均价为35.46,最高价位45.00,最低价为24.70。

EPS

HCM 新闻

更多
  • Chi-Med launches mid-stage HMPL-453 study in malignant mesothelioma
  • Seeking Alpha - Article · 3天前
  • Chi-Med Initiates a Phase II Trial of HMPL-453 in Patients with Advanced Malignant Mesothelioma in China
  • GlobeNewswire · 3天前
  • Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing
  • CNW Group · 03/26 13:35
  • 10 International ADR Companies That Are Conducting Virtual Investor Presentations This Week
  • Benzinga · 03/17 16:30

所属板块

制药
+2.64%
制药与医学研究
+2.80%

热门股票

代码
价格
涨跌幅

HCM 简况

Hutchison China Meditech Limited is an investment holding company principally engaged in the manufacture and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Manufacturing Business segment is engaged in the manufacture and distribution of drug products. The Distribution Business segment provides sales and marketing services to pharmaceutical manufacturers. The Company's products include prescription and over the counter (OTC) pharmaceuticals such as banlangen, fu fang dan shen tablets and shexiang baoxin pills and others, and consumer health products. In addition, the Company also develops targeted therapeutics and immunotherapies for oncology and autoimmune diseases.
展开

微牛提供Hutchison China MediTech Limited(NASDAQ-HCM)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的HCM股票新闻,以帮助您做出投资决策。